Using whole genome sequence findings to assess gene-disease causality in cardiomyopathy and arrhythmia patients

Future Cardiol. 2023 Sep;19(12):583-592. doi: 10.2217/fca-2023-0082. Epub 2023 Oct 13.

Abstract

Aim: The genetic etiologies of cardiomyopathies and arrhythmias have not been fully elucidated. Materials & methods: Research findings from genome analyses in a cardiomyopathy and arrhythmia cohort were gathered. Gene-disease relationships from two databases were compared with patient phenotypes. A literature review was conducted for genes with limited evidence. Results: Of 43 genes with candidate findings from 18 cases, 23.3% of genes had never been curated, 15.0% were curated for cardiomyopathies, 16.7% for arrhythmias and 31.3% for other conditions. 25.5% of candidate findings were curated for the patient's specific phenotype with 11.8% having definitive evidence. MYH6 and TPCN1 were flagged for recuration. Conclusion: Findings from genome sequencing in disease cohorts may be useful to guide gene-curation efforts.

Keywords: MYH6; TPCN1; arrhythmia; cardiomyopathy; gene curation; gene-disease validity; whole genome sequencing.

Publication types

  • Review

MeSH terms

  • Arrhythmias, Cardiac / genetics
  • Cardiomyopathies* / genetics
  • Humans
  • Phenotype